Related Experiment Video
Updated: Jul 4, 2025
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Inaugurating a novel adjuvant therapy in urological cancers: Ferroptosis
Zhaoxiang Xie1,2, Qianghua Zhou1,2, Cheng Qiu3
1Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China.
Abstract:
Ferroptosis, a distinctive form of programmed cell death, is involved in numerous diseases with specific characteristics, including certain cell morphology, functions, biochemistry, and genetics, that differ from other forms of programmed cell death, such as apoptosis. Many studies have explored ferroptosis and its associated mechanisms, drugs, and clinical applications in diseases such as kidney injury, stroke, ischemia-reperfusion injury, and prostate cancer. In this review, we summarize the regulatory mechanisms of some ferroptosis inducers, such as enzalutamide and erastin. These are current research focuses and have already been studied extensively. In summary, this review focuses on the use of ferroptosis induction as a therapeutic strategy for treating tumors of the urinary system.
Insights
Ferroptosis, a programmed cell death form, is key in diseases like cancer. This review explores ferroptosis inducers for treating urinary system tumors.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Ferroptosis is a distinct form of programmed cell death with unique characteristics.
- It differs from apoptosis in morphology, biochemistry, and genetics.
- Ferroptosis is implicated in various diseases, including kidney injury, stroke, and prostate cancer.
Purpose of the Study:
- To review the regulatory mechanisms of ferroptosis inducers.
- To focus on ferroptosis induction as a therapeutic strategy for urinary system tumors.
- To summarize current research on specific inducers like enzalutamide and erastin.
Main Methods:
- Literature review of ferroptosis research.
- Analysis of regulatory mechanisms of ferroptosis inducers.
- Synthesis of findings related to clinical applications in urinary system cancers.
Main Results:
- Ferroptosis exhibits distinct biochemical and genetic profiles.
- Enzalutamide and erastin are key ferroptosis inducers under extensive study.
- Ferroptosis induction shows therapeutic potential for specific cancers.
Conclusions:
- Ferroptosis is a significant therapeutic target.
- Induction of ferroptosis offers a promising strategy for treating urinary system tumors.
- Further research into ferroptosis mechanisms and inducers is warranted.
More Related Videos
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
